Eloxx Pharmaceuticals

ELOX45

Penny Stock

$0.690.00%$0.00

Penny Stock

ELOX45

$0.69

0.00%$0.00

Penny Stock

Performance History

Key Stats
Open	$0.60
Prev. Close	$0.69
EPS	-8.88
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$2.16M
PE Ratio	-

	LOW	HIGH
Day Range	0.52	0.69
52 Week Range	0.20	6.13

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-8.88

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Eloxx Pharmaceuticals (ELOX)

Eloxx Pharmaceuticals Inc (ELOX) is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for the treatment of rare and ultra-rare genetic diseases caused by nonsense mutations. The company's lead product candidate, ELX-02, is being developed for the treatment of cystic fibrosis and cystinosis, two debilitating genetic disorders that currently have limited treatment options. ELX-02 is designed to restore the production of functional proteins in patients with nonsense mutations, addressing the underlying cause of these diseases. The company is also exploring the potential of ELX-02 in other genetic diseases, such as Rett syndrome and Usher syndrome.

Eloxx Pharmaceuticals Inc aims to leverage its proprietary platform technologies, including its drug discovery platform and translational read-through platform, to identify and develop new therapies for a range of genetic diseases. The company's drug discovery platform integrates a variety of computational tools and experimental approaches to identify and optimize potential drug candidates. The translational read-through platform is designed to select patients who are most likely to respond to the company's therapies based on genetic biomarkers and disease-specific characteristics.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Sumit Aggarwal M.B.A.
Headquarters: Watertown
Employees: 18
Exchange: NASDAQ

Keep an eye on Eloxx Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Eloxx Pharmaceuticals 's (ELOX) price per share?

The current price per share for Eloxx Pharmaceuticals (ELOX) is $0.69. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Eloxx Pharmaceuticals (ELOX)?

For Eloxx Pharmaceuticals (ELOX), the 52-week high is $6.13, which is 788.41% from the current price. The 52-week low is $0.2, the current price is 245% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Eloxx Pharmaceuticals (ELOX) a growth stock?

Eloxx Pharmaceuticals (ELOX) has shown an average price growth of 0.41% over the past three years. It has received a score of -3 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Eloxx Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Eloxx Pharmaceuticals (ELOX) stock price performance year to date (YTD)?

As of the latest data, Eloxx Pharmaceuticals (ELOX) has a year-to-date price change of -24.18%. Over the last three months, the change has been 1.47%. Over the past six months, the figure is -35.51%. Looking at a longer horizon, the five-year price change stands at -99.73%.

help

Is Eloxx Pharmaceuticals (ELOX) a profitable company?

Eloxx Pharmaceuticals (ELOX) has a net income of -$20.48M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$19.29M. Furthermore, the EBITDA is -$19.24M.

help

What is the market capitalization of Eloxx Pharmaceuticals (ELOX)?

Eloxx Pharmaceuticals (ELOX) has a market capitalization of $2.17M. The average daily trading volume is 1.3K, indicating the stock's liquidity and investor engagement.